Sort
30,917 grants matching “tumor microenvironment”
The Tumor Microenvironment and Lymphatic Remodeling in Postpartum Breast Cancer
$562,029Jasmine Alise McDonald · Columbia University Health Sciences · R01 · FY2022 · CA
Molecular Genomics Core
$561,998David W Craig · University Of Southern California · P30 · FY2024 · CA
Circadian Clock Disruption and Colorectal Cancer
$561,917Selma Masri · University Of California-Irvine · R01 · FY2025 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$561,881Jin-Ming Yang · University Of Kentucky · R01 · FY2021 · CA
DEFINING THE EFFECTS OF JAK/STAT INHIBITION ON THE TUMOR MICROENVIRONMENT
$561,873Regents Of The University Of Minnesota · · FY2016 · Department of the Army
Tumor immune and glycan biomarkers for progressive prostate cancer
$561,790Jennifer D Wu · Northwestern University At Chicago · R01 · FY2021 · CA
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
$561,772Andrew James Aguirre · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
$561,772Andrew James Aguirre · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$561,734David G Denardo · Washington University · R01 · FY2024 · CA
Immunometabolic Programs Controlled by ER Stress in Cancer
$561,680Juan R Cubillos-Ruiz · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Heparan Sulfate in Prostate Cancer
$561,653Lianchun Wang · University Of South Florida · U01 · FY2019 · CA
A deubiquitination module controls Treg adaptation to tumor microenvironment
$561,629Deyu Fang · Northwestern University At Chicago · R01 · FY2021 · CA
Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
$561,617Xiaoguang Margaret Liu · Ohio State University · R01 · FY2023 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$561,558Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
Transmembrane Proteases and Prostate Carcinogenesis
$561,546Robert Vessella · University Of Washington · P01 · FY2011 · CA
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$561,441Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2023 · CA
Clinical Trials and Translation
$561,437Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
Regulation of anti-tumor immunity by HDAC11
$561,377Edward Seto · George Washington University · R01 · FY2023 · CA
Modulation of the tumor microenvironment with probiotic therapies
$561,341Tal Danino · Columbia Univ New York Morningside · R01 · FY2022 · CA
Tumor Immune MicroEnvironment Facility (Scientific Core)
$561,301Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$561,099Efstathios Karathanasis · Case Western Reserve University · R01 · FY2024 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$560,974Gerald V Denis · Boston University Medical Campus · U01 · FY2021 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$560,955Hai-Quan Mao · Johns Hopkins University · R01 · FY2023 · CA
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
$560,831Ashutosh Agarwal · University Of Miami School Of Medicine · U01 · FY2019 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
$560,797Laura Rozek · Georgetown University · R01 · FY2024 · CA